Home/Filings/4/0001209191-19-024251
4//SEC Filing

SCHNELL DAVID 4

Accession 0001209191-19-024251

CIK 0001426332other

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 4:38 PM ET

Size

15.5 KB

Accession

0001209191-19-024251

Insider Transaction Report

Form 4
Period: 2019-04-08
Transactions
  • Conversion

    Series A Preferred Stock

    2019-04-083,000,0000 total(indirect: See Footnotes)
    Common Stock (3,000,000 underlying)
  • Conversion

    Series C Preferred Stock

    2019-04-08525,0000 total(indirect: See Footnotes)
    Common Stock (525,000 underlying)
  • Conversion

    Series D Preferred Stock

    2019-04-08100,0000 total(indirect: See Footnotes)
    Common Stock (100,000 underlying)
  • Conversion

    Common Stock

    2019-04-08+4,925,0004,925,000 total(indirect: See Footnotes)
  • Conversion

    Series B Preferred Stock

    2019-04-081,300,0000 total(indirect: See Footnotes)
    Common Stock (1,300,000 underlying)
Footnotes (7)
  • [F1]Every two shares of Series A preferred stock, Series B preferred stock, Series C preferred stock and Series D preferred stock automatically converted into one share of common stock in connection with the closing of the issuer's initial public offering. These shares have no expiration date.
  • [F2]Consists of 4,925,000 shares beneficially owned by Prospect Ventures Partners III, L.P.
  • [F3]The Reporting Person, a Director of the Issuer, shares voting and dispositive power with the managing members of Prospect Management Co. III, L.L.C., which is the general partner of Prospect Ventures Partners III, L.P., but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  • [F4]Consists of 3,000,000 shares beneficially owned by Prospect Ventures Partners III, L.P.
  • [F5]Consists of 1,300,000 shares beneficially owned by Prospect Ventures Partners III, L.P.
  • [F6]Consists of 525,000 shares beneficially owned by Prospect Ventures Partners III, L.P.
  • [F7]Consists of 100,000 shares beneficially owned by Prospect Ventures Partners III, L.P.

Issuer

NGM BIOPHARMACEUTICALS INC

CIK 0001426332

Entity typeother

Related Parties

1
  • filerCIK 0001162060

Filing Metadata

Form type
4
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:38 PM ET
Size
15.5 KB